Please reach us at jack@disruptconnect.com if you cannot find an answer to your question.
Biotech and life sciences across therapeutics, diagnostics, tools, CDMOs/CROs, synthetic biology, and enabling technologies.
Yes—with adjacent deep‑tech and healthcare‑adjacent categories. The same clarity‑to‑execution disciplines apply.
With a 45‑minute Clarity Call to map outcomes, scope, and fit. From there, we propose a timeboxed sprint or phased program.
Yes. We’ll sequence modules so handoffs are clean and outcomes are measurable.
We treat it as progress—redirect, reframe, or stop. The goal is smart allocation, not sunk‑cost momentum.
We design for leverage—prioritized bets, small experiments, and right‑sized cadences.
Absolutely. We embed with your teams and make them more effective.
Fixed‑scope sprints for speed and clarity; phased programs or retainers for ongoing support (e.g., Activation Engine, Control Tower, Advisory). No hidden fees.
Primarily remote with optional onsite workshops when beneficial.
We sign NDAs, use least‑privilege access, and never use your data to train public models. Human‑in‑the‑loop reviews are standard.
As an accelerator inside governed workflows. Humans approve anything external‑facing; claims and disclosures follow your policies.
Available on request (under NDA when needed). We can provide anonymized samples in the meantime.